5.34Open5.50Pre Close2 Volume37 Open Interest73.00Strike Price1.07KTurnover55.54%IV0.45%PremiumDec 6, 2024Expiry Date4.99Intrinsic Value100Multiplier4DDays to Expiry0.35Extrinsic Value100Contract SizeAmericanOptions Type0.8711Delta0.0446Gamma15.60Leverage Ratio-0.1200Theta0.0074Rho13.59Eff Leverage0.0179Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
Great products sells itself, ask novo disk and how they sell ozempic
No comment yet